- Home >
- Life Sciences >
- Pharmaceutical >
- Drug Discovery and Development >
Drug Discovery and Development Industry Analysis and Statistics (since 2008)
Refine results by
Publication dates
All premium reports for Drug Discovery and Development Industry Analysis and Statistics (since 2008)
1-24 of 24 Premium Reports from 10 Publishers
China chinese patent drug processing industry, 2010
- $ 4 000
- February 2010
China chinese patent drug processing Industry, 2010 is valuable for anyone who wants to invest in the chinese patent drug processing industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of ...
Industries : Drug Discovery and Development
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- $ 3 500
- February 2010
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and CostsSummaryGBI Research, the leading business intelligence provider, has released its latest research, ?Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs?. The report provides an in-depth analysis of the ...
Industries : Biotechnology, Drug Discovery and Development
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting
- $ 3 500
- February 2010
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost CuttingSummaryGBI Research, the leading business intelligence provider, has released its latest report, ?Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting.? It provides k ...
Industries : Drug Discovery and Development
Competitor Analysis c-Met/HGF Inhibitors
- $ 375
- February 2010
Product descriptionThe Competitive Intelligence Report c-MET/HGF Inhibitors as of February 2010 provides a competitor analysis in the development pipeline of novel emerging inhibitors of c-MET receptor tyrosine kinase (RTK) and its ligand hepatocyte growth factor (HGF) or scatter factor (SF) for tre ...
Industries : Biotechnology, Drug Discovery and Development
Competitor Analysis BlyS, BAFF & APRIL
- $ 125
- February 2010
Competitor Analysis: BlyS, BAFF & APRILProduct descriptionThe present Competitive Intelligence Report about BlyS, BAFF & APRIL Targeted Therapy provides a competitor evaluation in the field of molecules targeting B-lymphocyte stimulator (BlyS), B-cell activating factor of the TNF family (BAFF) and o ...
Industries : Biotechnology, Drug Discovery and Development, Therapy
Competitor Analysis Notch Pathway Inhibitors
- $ 125
- February 2010
Product descriptionThe present Competitive Intelligence Report about Notch Pathway Inhibitors provides a competitor evaluation in the field of molecules targeting Notch via gamma-secretase or its vascular ligand delta-like ligand-4 (DLL4) as of February 2010. Purchase of the downloadable pdf report ...
Industries : Biotechnology, Drug Discovery and Development
DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
- $ 3 835
- January 2010
The advent of DNA sequencing technology has had a vast impact on the field of drug development. It has played a key role in the success of the Human Genome Project which has made it an essential tool for genetic analysis. Advanced technological developments in microarrays, bioinformatics and simila ...
Industries : Drug Discovery and Development
Genta Incorporated - SWOT Analysis
- $ 125
- December 2009
Genta Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. Genta Incorporated - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...
Industries : Drug Discovery and Development
ZymoGenetics, Inc. - SWOT Analysis
- $ 125
- December 2009
ZymoGenetics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. ZymoGenetics, Inc. - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and st ...
Industries : Drug Discovery and Development
Discovery Laboratories, Inc. - SWOT Analysis
- $ 125
- December 2009
Discovery Laboratories, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Discovery Laboratories, Inc. - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key ...
Industries : Biotechnology, Drug Discovery and Development
Stakeholder Insight: Osteoarthritis - Drug development lags behind rising osteoarthritis population
- $ 15 200
- December 2009
IntroductionDatamonitor expect osteoarthritis prevalence to grow by over 10 million by 2020, owing mainly to an aging population. In the near-term the approach to treatment will remain constant, with improved side-effects dominating the unmet needs. However, therapies which target the underlying cau ...
Industries : Drug Discovery and Development
Pharmacodynamic Assays
- $ 2 995
- December 2009
Pharmacodynamic assays are assays that provide methods for quickly screening cell samples for a pharmacodynamic effect to a drug or test agent. These assays inform drug development decisions by providing evidence of drug action on molecular targets.Pharmacodynamic assay development has become an inc ...
Industries : Biotechnology, Drug Discovery and Development
Proteomics - International Market Trends
- $ 2 995
- November 2009
The shift from genomics to proteomics paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput and increased resolution from traditional protein research tools. A major market growth driver is the explosion in scientific discov ...
Industries : Genomics, Drug Discovery and Development
Bioinformatics - A Global Market Intelligence Report
- $ 3 450
- November 2009
Bioinformatics is a key discipline operating on the forefront of the biotech revolution. Despite dynamic potential, Bioinformatics remains a challenging industry, in part due to its still evolving status. A significant challenge in bioinformatics remains incorporation of different sources into one v ...
Industries : Biotechnology, Drug Discovery and Development
Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
- $ 2 995
- November 2009
Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are increasingly being used to enhance pharmaceutical R&D. These technologies include bioanalytical instruments, genomics, pharmacogenomics, com ...
Industries : Medical Equipment and Supply, Drug Discovery and Development
2010 U.S. Pharmaceutical Preparation Mfg. Industry Report
- $ 149
- October 2009
The Pharmaceutical Preparation Mfg. Industry report, contains timely and accurate industry statistics, forecasts and demographics. The report features 2010 current and 2011 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and o ...
Industries : Drug Discovery and Development, Pharmacies and Drug Stores
Emerging Clinical Trial Locations ? Eastern Europe: Market dynamics and the changing healthcare and regulatory environment
- $ 3 835
- June 2009
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both ...
Industries : Drug Discovery and Development
Emerging Clinical Trial Locations ? China: Market dynamics and the changing healthcare and regulatory environment
- $ 3 835
- June 2009
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both ...
Industries : Drug Discovery and Development
Emerging Clinical Trial Locations ? India: Market dynamics and the changing healthcare and regulatory environment
- $ 3 835
- June 2009
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both ...
Industries : Drug Discovery and Development
Emerging Clinical Trial Locations ?Latin America: Market dynamics and the changing healthcare and regulatory environment
- $ 3 835
- June 2009
Over the last decade pharmaceutical and biotechnology companies have entered a period where they have become confronted by a variety of complex issues affecting their operational efficiency and profitability. It has now become generally acknowledged that the current business models have become both ...
Industries : Drug Discovery and Development
Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- $ 3 835
- June 2009
Key Trends in Drug-Diagnostic Co-DevelopmentIdentifying collaborative opportunities and navigating regulatory challengesReport OverviewThe development of genomics-based molecular diagnostics that are linked to therapeutic products is critical to targeted drug developments of the future. The potentia ...
Industries : Drug Discovery and Development
Statins: The World Market, 2009-2024
- $ 2 501
- March 2009
The world statins market is changing, with patent expires and maturity of the landmark product Lipitor (atorvastatin). Statins are at the forefront of strategies to combat dyslipidaemia, being pivotal in the prevention of coronary heart disease. Consequently, those drugs are one of the most widely-p ...
Industries : Drug Discovery and Development
Biotech Success Rates - Going the Wrong Way
- $ 1 238
- March 2009
The report "Success Rates in Biotech - Going The Wrong Way" summarizes our review of 211 public biotech companies comprising over 1,500 drug development projects. We have studied the clinical pipelines going back to 2002 based on financial reports and found a striking difference of success probabili ...
Industries : Biotechnology, Drug Discovery and Development
Poly(ADP-ribose) polymerase (PARP) Research Products
- $ 2 995
- March 2009
This PARP Research Products market report explores are a superfamily of 18 proteins, of which PARP-1 is the best characterized. They are enzymes that are activated by DNA breaks to facilitate DNA repair.Currently, there is a great deal of research being done on this family of polymerases, because i ...
Industries : Biotechnology, Drug Discovery and Development
reportlinker.com © Copyright 2010. All rights reserved